Skip to content

13F-HR filed by Eagle Health Investments LP

Eagle Health Investments LP filed this 13F-HR for the quarter ended 2021-09-30, filed 2021-10-20, with 27 holding rows worth $315,319,000.

Accession
0001842545-21-000005
Filed
2021-10-20
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2021

A holdings report, 27 entries on the cover page, a total value of $315,319,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $315,319,000 with VALUE read as thousands by filing date, 13F file number 028-20556. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ASTRAZENECA PLC SPONSORED ADR046353108ADR449,565$27,001,000thousands by filing date
HUMANA INC COM444859102Stock68,521$26,665,000thousands by filing date
IQVIA HLDGS INC COM46266C105Stock81,177$19,445,000thousands by filing date
NATERA INC COM632307104Stock164,494$18,331,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM176,175$18,113,000thousands by filing date
UNITED THERAPEUTICS CORP DEL COM91307C102Stock98,038$18,096,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock90,102$17,012,000thousands by filing date
OUTSET MEDICAL INC690145107COM332,800$16,454,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR53,632$16,197,000thousands by filing date
DEXCOM INC COM252131107Stock29,500$16,132,000thousands by filing date
INSPIRE MED SYS INC COM457730109Stock68,653$15,988,000thousands by filing date
ADAPTIVE BIOTECHNOLOGIES CORP COM00650F109Stock441,466$15,005,000thousands by filing date
AXONICS INC05465P101COM190,365$12,391,000thousands by filing date
GUARDANT HEALTH INC COM40131M109Stock95,660$11,958,000thousands by filing date
AGIOS PHARMACEUTICALS INC00847X104COM235,513$10,869,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM52,000$9,199,000thousands by filing date
CANO HEALTH INC13781Y103COM676,412$8,577,000thousands by filing date
AMERICAN WELL CORP03044L105CL A901,300$8,211,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM406,525$8,196,000thousands by filing date
CAREMAX INC14171W103COM616,770$5,958,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM29,544$5,359,000thousands by filing date
KYMERA THERAPEUTICS INC501575104COM37,000$2,173,000thousands by filing date
C4 THERAPEUTICS INC12529R107COM STK47,200$2,109,000thousands by filing date
ARVINAS INC04335A105COM23,000$1,890,000thousands by filing date
4D MOLECULAR THERAPEUTICS INC COM35104E100Stock57,090$1,540,000thousands by filing date
LYELL IMMUNOPHARMA INC55083R104COM100,000$1,480,000thousands by filing date
OLINK HLDG AB680710100ADR40,000$970,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001842545-21-000005this filing2021-10-20acceptance time not in the bulk data set